Dow Up0.11% Nasdaq Up0.50%

NeurogesX, Inc. (NGSX)

-Other OTC
0.00 0.00(0.00%) Aug 27
|After Hours : 0.28 0.00 (0.00%) 4:13PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2012Jun 30, 2012Mar 31, 2012Dec 31, 2011
Total Revenue 2,834   3,057   2,973   2,958  
Cost of Revenue72  94  681  151  
Gross Profit 2,762   2,963   2,292   2,807  
Operating Expenses
Research Development1,326  1,539  2,933  2,412  
Selling General and Administrative2,776  3,424  7,263  7,537  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,340) (2,000) (7,904) (7,142)
Income from Continuing Operations
Total Other Income/Expenses Net -  (5)(48)8  
Earnings Before Interest And Taxes(1,340)(2,005)(7,952)(7,134)
Interest Expense2,475  3,468  3,220  3,107  
Income Before Tax(3,815)(5,473)(11,172)(10,241)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,815)(5,473)(11,172)(10,241)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,815) (5,473) (11,172) (10,241)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,815) (5,473) (11,172) (10,241)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.